Western Australian Current Acts

VOLUNTARY ASSISTED DYING ACT 2019 - SECT 69

69 .         Information to be given before prescribing substance

        (1)         In this section —

        Schedule 4 poison and Schedule 8 poison have the meanings given in the Medicines and Poisons Act 2014 section 3.

        (2)         The coordinating practitioner for a patient who has made a self-administration decision must, before prescribing a voluntary assisted dying substance for the patient, inform the patient, in writing, of the following —

            (a)         the Schedule 4 poison or Schedule 8 poison, or combination of those poisons, constituting the substance;

            (b)         that the patient is not under any obligation to obtain the substance;

            (c)         that the patient is not under any obligation to self-administer the substance;

            (d)         that the substance must be stored in accordance with the information provided by the authorised supplier who supplies the substance;

            (e)         how to prepare and self-administer the substance;

            (f)         the method by which the substance will be self-administered;

            (g)         the expected effects of self-administration of the substance;

            (h)         the period within which the patient is likely to die after self-administration of the substance;

                  (i)         the potential risks of self-administration of the substance;

            (j)         that, if the patient decides not to self-administer the substance, their contact person must give the substance to an authorised disposer for disposal;

            (k)         that, if the patient dies, their contact person must give any unused or remaining substance to an authorised disposer for disposal.

        (3)         The coordinating practitioner for a patient who has made a practitioner administration decision must, before prescribing a voluntary assisted dying substance for the patient, inform the patient, in writing, of the following —

            (a)         the Schedule 4 poison or Schedule 8 poison, or combination of those poisons, constituting the substance;

            (b)         that the patient is not under any obligation to have the substance administered;

            (c)         the method by which the substance will be administered;

            (d)         the expected effects of administration of the substance;

            (e)         the period within which the patient is likely to die after administration of the substance;

            (f)         the potential risks of administration of the substance;

            (g)         that, if the practitioner administration decision is made after the revocation of a self-administration decision, the contact person for the patient must give any prescribed substance received by the patient, the contact person or an agent of the patient to an authorised disposer for disposal.